Featured Post

Latest Gold News

Weak dollar, equities supporting gold Trump remains unimpressed with NAFTA   Business cycle winding down says Wall Street banks Klon...

Friday, December 30, 2011

Amgen (AMGN) (ALXN) (FRNK) (BIDU) (CEDU) (KEM) Ratings, Price Targets

Amgen, Inc. (NASDAQ: AMGN), Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN), Franklin Financial (NASDAQ: FRNK), Baidu.com, Inc. (NASDAQ: BIDU), ChinaEdu (NASDAQ: CEDU) and KEMET Co. (NYSE: KEM) ratings and price targets.

Amgen, Inc. (AMGN) had its price target raised by Bank of America (NYSE:BAC) to $65.00.

Alexion Pharmaceuticals, Inc. (ALXN) had its “Outperform” rating reiterated by Leerink Swann.

Sandler O'Neill initiated coverage on Franklin Financial (FRNK). They placed a “Hold” rating on the company.

Baidu.com, Inc. (BIDU) was downgraded by Zacks Investment Research from an “Outperform” rating to a “Neutral” rating.

ChinaEdu (CEDU) was downgraded by Zacks Investment Research from a “Neutral” rating to an “Underperform” rating.

KEMET Co. (KEM) was upgraded by Zacks Investment Research from an “Underperform” rating to a “Neutral” rating.

No comments: